<DOC>
	<DOCNO>NCT00635258</DOCNO>
	<brief_summary>This prospective randomized study perform evaluate whether replacement GnRH agonist GnRH antagonist oocyte donation recipient endometrial preparation impact pregnancy implantation rate .</brief_summary>
	<brief_title>Administration GnRH Antagonist Oocyte Donation Recipients</brief_title>
	<detailed_description>This prospective randomized study undertaken January 2004 December 2007 . One hundred patient indication oocyte donation function ovary IVF without intracytoplasmatic sperm injection ( ICSI ) recruit study . After assignment IVF IVF/ICSI randomization perform 1 2 treatment group ( GnRH agonist GnRH antagonist endometrial preparation oocyte donation recipient ) use computed-generated randomization schedule assign via number sealed envelope . In program , use excess oocyte IVF voluntarily donate patient informed consent . The indication oocyte donation reduce ovarian reserve ( 59 % ) , recurrent IVF failure ( 21 % ) , premature ovarian failure ( 16 % ) , genetic anomaly ( 4 % ) . This study perform accord declaration Helsinki European Community note Good Clinical Practice trial medical product European Community ( CPMP Working Party Efficacy Medical Products , 1990 ) . Furthermore , local ethic committee approve study protocol , write informed consent obtain patient .</detailed_description>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<criteria>Age 1834 year Body mass index 1930 kg/m2 ; History regular menstrual cycle , range 2535 day No relevant systemic disease ( patient screen hepatitis B C , human immunodeficiency virus I II , syphylis , vaginal infection ) , genetic disease , severe endometriosis pelvic inflamatory disease No two previous IVF cycle ; No previous IVF cycle poor response ( less three oocyte previous IVF cycle ) severe ovarian hyperstimulation syndrome . Patients without inclusion criterion .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>34 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>GnRH antagonist</keyword>
	<keyword>oocyte donation</keyword>
	<keyword>pregnancy</keyword>
	<keyword>implantation</keyword>
</DOC>